Key Dates
NOT-AA-23-005 - Notice of Intent to Publish a Funding Opportunity Announcement for HIV Prevention and Alcohol (R01 Clinical Trials Optional)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
The FOA seeks to expand the HIV/AIDS prevention toolkit among alcohol impacted populations with a range of patterns of episodic and long-term use and associated behavioral and biological risks for HIV acquisition. This includes integration of effective prevention and treatment interventions with an understanding of the overarching framework for reducing the incidence of new infections by facilitating cross-cutting informative research.
This R34 Funding Opportunity Announcement (FOA) supports studies that are both necessary and sufficient to inform the planning of a clinical trial within the scope of the companion announcement [enter R01 PAS here], HIV Prevention and Alcohol (R01 Clinical Trials Optional). The NIAAA expects that applications to this FOA will describe the planned clinical trial and in so doing demonstrate that the proposed (R34) research is scientifically necessary to design or plan the subsequent trial. Furthermore, this FOA will support research projects that are designed to provide results that will be sufficient to inform the future trial without further studies. The planned Phase II, III, or IV trial must be primarily intended to test the efficacy, safety, clinical management, or implementation of intervention(s) in the prevention of HIV. In this NIAAA funding opportunity for pilot clinical trials the R34 mechanism is intended to provide new information that answers a scientific or operational question(s) which may be pragmatic in nature and, therefore, informs the final development of a clinical trial and testing of intervention tools.
This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.
The FOA is expected to be published in Spring 2023 with an expected application due date in Spring 2023.
This FOA will utilize the R34 Clinical Trials Optional activity code. Details of the planned FOA are provided below.
This Notice encourages investigators with expertise and insights into these areas of behavorial, biological, and clinical science to begin to consider applying for this new FOA for planning or pilot research activities.
In addition, collaborative investigations combining expertise in these areas will be encouraged and these investigators should also begin considering applying for this new FOA.
The areas of research encouraged in this initiative may also be designed to improve the translation of existing knowledge of strategies for the prevention and treatment of alcohol misuse to impact the prevention of infection and transmission of HIV.
TBD
$1,500,000
2 - 4
$450,000 direct costs for up to 3 years, with $225,000 direct costs requested in a single year.
93.273
Private Institution of Higher Education
Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education)
Small Business
For-Profit Organization (Other than Small Business)
State Government
Indian/Native American Tribal Government (Federally Recognized)
County governments
Independent school districts
Public housing authorities/Indian housing authorities
Indian/Native American Tribally Designated Organization (Native American tribal organizations (other than Federally recognized tribal governments)
U.S. Territory or Possession
Indian/Native American Tribal Government (Other than Federally Recognized)
Non-domestic (non-U.S.) Entity (Foreign Organization)
Regional Organization
Eligible Agencies of the Federal Government
Applications are not being solicited at this time.
Please direct all inquiries to:
Office of Extramural Activities
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Email: niaaaoea@mail.nih.gov
Scientific/Research Contact(s)
Kendall Bryant, Ph.D.
Office of the Director, HIV/AIDs
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Telephone: 301-402-0332
Email:kbryant@mail.nih.gov
and Human Services (HHS)
